Skip to content

STUDY TO ASSESS THE THERAPEUTIC IMPACT OF PLACENTAL EXTRACT INJECTION ON PELVIC INFLAMMATORY DISEASE

AN OPEN PROSPECTIVE RANDOMIZED CONTROLLED STUDY ON ASSESSING THE THERAPEUTIC IMPACT OF PLACENTAL EXTRACT INJECTION ON PELVIC INFLAMMATORY DISEASE - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104330
Enrollment
90
Registered
2026-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: INJECTION PLACENTAL EXTRACT: ORAL DOXYCYCLINE100 MG BD 14DAYS ,ORAL METRONIDAZOLE 500MG BD 14DAYS ALONG WITH INJ PLACENTAL EXTRACT 1 AMP FOR 7 DAYS IM , Control Intervention1: NO INJ

Sponsors

Neelambika Nagur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females of reproductive age /childbearing age 18 and above Patients who are willing to undergo follow-ups/injections/ diagnostic and assessments evaluating efficacy.

Exclusion criteria

Exclusion criteria: Pregnancy Lactating women Allergic to treatment Active TB/ STD on treatment Post menopausal women

Design outcomes

Primary

MeasureTime frame
Prevent long-term complications such as infertility, chronic pelvic pain, ectopic pregnancy, abscess and hysterectomy Failure of antibiotic therapy to prevent the sequelae of salpingitis To eradicate the infection and prevent transmission Timepoint:

Secondary

MeasureTime frame
1.To assess the overall improvement & quality of life & reduction in pain & discomfort with PID following treatment with placental extract Tracking these outcomes helps researchers & clinicians determine the effectiveness of various therapeutic approaches & improve management strategies for PID. Timepoint: 6 WEEKS TO 8 WEEKS FOLLOW UP

Countries

India

Contacts

Public ContactDR SHAILAJA R BIDRI

Shri B.M.Patil medical college hospital and research center

drsrbidri1@gmail.com9880162550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026